Background: Locally advanced non-small cell lung cancer (LA-NSCLC) needs a multidisciplinary management and patients undergoing an intentional to treat pathway have also a high risk of recurrence even after neoadjuvant chemotherapy followed by curative resection. Recently, perioperative chemoimmunotherapy (CIO) changed the treatment paradigm. However, literature is lacking in the comparison of the post-operative outcomes in elderly patients. The aim of this study was to assess the postoperative results of perioperative CIO in patients aged ≥70 years. Methods: We conducted a single-center retrospective analysis on patients with clinical stage IIB–IIIB NSCLC who underwent treatment between January 2015 and June 2025. We compared post-operative outcomes of patients who received perioperative CIO with a control group of patients who received standard chemotherapy stratifying the study population focusing on elderly patients. Results: In the study period we identified 174 patients with stage IIB–IIIB NSCLC underwent lung surgery after standard chemotherapy (n=121) or CIO (n=53) and among these elderly represented 42.9% and 32.1% respectively. Ninety-day mortality was 2.4% vs. 0%. At least one complication was observed in 47.9% vs. 32.1%, P=0.07, whereas major complications (Clavien-Dindo > 3b) were developed in 11.5% vs. 1%, respectively (P=0.07). In the elderly population, major complications were observed in 13.46% vs. 0% (P=0.02). Pneumonectomy and DLCO% less than 60% of the predicted were associated with an increased risk of complications at the univariate analysis, whereas video-assisted thoracoscopic surgery (VATS) and CIO were associated with a decrease. The multivariable analysis model did not show any significant predictive factor for the development of post-operative complications. Conclusions: Lung resection after perioperative CIO is feasible and safe even in elderly patients, without major or life-threatening complications.
Post-operative outcomes of lung resection after perioperative chemoimmunotherapy for stage IIB–IIIB non-small-cell lung cancer in the elderly: a single center real-life experience / Bongiolatti S., Mugnaini G., Viggiano D., Gatteschi L., Tombelli S., Mazzoni F., Caliman E., Fancelli S., Frongia F., Gonfiotti A., Voltolini L.. - In: JOURNAL OF THORACIC DISEASE. - ISSN 2072-1439. - ELETTRONICO. - 18:(2026), pp. 381.381-381.381. [10.21037/jtd-2025-aw-2048]
Post-operative outcomes of lung resection after perioperative chemoimmunotherapy for stage IIB–IIIB non-small-cell lung cancer in the elderly: a single center real-life experience
Bongiolatti S.;Caliman E.;Fancelli S.;Gonfiotti A.;Voltolini L.
2026
Abstract
Background: Locally advanced non-small cell lung cancer (LA-NSCLC) needs a multidisciplinary management and patients undergoing an intentional to treat pathway have also a high risk of recurrence even after neoadjuvant chemotherapy followed by curative resection. Recently, perioperative chemoimmunotherapy (CIO) changed the treatment paradigm. However, literature is lacking in the comparison of the post-operative outcomes in elderly patients. The aim of this study was to assess the postoperative results of perioperative CIO in patients aged ≥70 years. Methods: We conducted a single-center retrospective analysis on patients with clinical stage IIB–IIIB NSCLC who underwent treatment between January 2015 and June 2025. We compared post-operative outcomes of patients who received perioperative CIO with a control group of patients who received standard chemotherapy stratifying the study population focusing on elderly patients. Results: In the study period we identified 174 patients with stage IIB–IIIB NSCLC underwent lung surgery after standard chemotherapy (n=121) or CIO (n=53) and among these elderly represented 42.9% and 32.1% respectively. Ninety-day mortality was 2.4% vs. 0%. At least one complication was observed in 47.9% vs. 32.1%, P=0.07, whereas major complications (Clavien-Dindo > 3b) were developed in 11.5% vs. 1%, respectively (P=0.07). In the elderly population, major complications were observed in 13.46% vs. 0% (P=0.02). Pneumonectomy and DLCO% less than 60% of the predicted were associated with an increased risk of complications at the univariate analysis, whereas video-assisted thoracoscopic surgery (VATS) and CIO were associated with a decrease. The multivariable analysis model did not show any significant predictive factor for the development of post-operative complications. Conclusions: Lung resection after perioperative CIO is feasible and safe even in elderly patients, without major or life-threatening complications.| File | Dimensione | Formato | |
|---|---|---|---|
|
jtd-18-04-381.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Creative commons
Dimensione
447.07 kB
Formato
Adobe PDF
|
447.07 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.



